Pharmaceutical group

Alembic

84 medicines4 countries

A group of 4 companies with 84 medicines in 4 countries.

Its medicines

Group structure

4 companies in 1 country

United States2

Headquarters not stated2

Alembic Pharmaceuticals LimitedAuthorisation holder · 53 medicines · listed in Brazil, Canada +2
Alembic Pharmaceuticals Europe LimitedAuthorisation holder · 30 medicines · listed in Spain, Netherlands

Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.

Medicines

Every medicine of every company in the group, current ones first.

1–25 of 84

Medicine	Substance	Country	Status	Authorised
ALEMBIC-BOSENTAN62.5 mg · Tablet	Bosentan	Canada	Authorised
ALEMBIC-BOSENTAN125 mg · Tablet	Bosentan	Canada	Authorised
ALEMBIC-DEFERASIROX (TYPE J)360 mg · Tablet	Deferasirox	Canada	Authorised
ALEMBIC-LACOSAMIDE150 mg · Tablet	Lacosamide	Canada	Authorised
ALEMBIC-LACOSAMIDE50 mg · Tablet	Lacosamide	Canada	Authorised
ALEMBIC-LACOSAMIDE200 mg · Tablet	Lacosamide	Canada	Authorised
ALEMBIC-LACOSAMIDE100 mg · Tablet	Lacosamide	Canada	Authorised
ALEMBIC-TELMISARTAN80 mg · Tablet	Telmisartan	Canada	Authorised
ALEMBIC-TELMISARTAN40 mg · Tablet	Telmisartan	Canada	Authorised
ALEMBIC-TELMISARTAN/HCTZ25 mg + 80 mg · Tablet	Hydrochlorothiazide, Telmisartan	Canada	Authorised
ALEMBIC-TELMISARTAN/HCTZ12.5 mg + 80 mg · Tablet	Hydrochlorothiazide, Telmisartan	Canada	Authorised
AMANTADINE HYDROCHLORIDE100mg · Capsule	Amantadine	United States	Marketed	1987
ARIPIPRAZOLE10mg \| 15mg \| 20mg \| 30mg · Tablet, orally disintegrating	Aripiprazole	United States	Marketed	2012
BETAMETHASONE VALERATE0.12% · Aerosol, foam	Betamethasone	United States	Marketed	2012
BIMATOPROST0.03% · Solution/drops	Bimatoprost	United States	Marketed	2014
BOSUTINIB MONOHYDRATE100mg base \| 500mg base · Tablet	Bosutinib	United States	Marketed	2025
CANDESARTAN CILEXETIL4 mg · Tablet	Candesartan cilexetil	Canada	Authorised
CANDESARTAN CILEXETIL32 mg · Tablet	Candesartan cilexetil	Canada	Authorised
CANDESARTAN CILEXETIL16 mg · Tablet	Candesartan cilexetil	Canada	Authorised
CANDESARTAN CILEXETIL8 mg · Tablet	Candesartan cilexetil	Canada	Authorised
CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE TABLETS16 mg + 12.5 mg · Tablet	Candesartan cilexetil, Hydrochlorothiazide	Canada	Authorised
CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE TABLETS32 mg + 12.5 mg · Tablet	Candesartan cilexetil, Hydrochlorothiazide	Canada	Authorised
CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE TABLETS32 mg + 25 mg · Tablet	Candesartan cilexetil, Hydrochlorothiazide	Canada	Authorised
CELECOXIB200 mg · Capsule	Celecoxib	Canada	Authorised
CELECOXIB100 mg · Capsule	Celecoxib	Canada	Authorised

Sources and licences

Country	Medicines	Current	Past	Companies
Canada	31	31	0	Companies All medicines
United States	23	20	3	Companies All medicines
Spain	22	8	14	Companies All medicines
Netherlands	8	8	0	Companies All medicines

Compiled by Prognia from the public medicine and company registers below. Logos are not used.

Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.

Agencia Española de Medicamentos y Productos Sanitarios (CIMA)

Fuente de la información: AEMPS (CIMA).

Licence: AEMPS open data reuse with attribution

U.S. Food and Drug Administration (Drugs@FDA, openFDA)

Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.

Licence: Public domain (U.S. Government work)

Anvisa, Brazil

Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.

Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions

Health Canada, Canada

Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

All 9 sources

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim

Health Sciences Authority / data.gov.sg

Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence

Licence: Singapore Open Data Licence

Report an error or request removalCorrections from the company itself are welcome.

Alembic

Group structure

United States2

Headquarters not stated2

Medicines

Know your medicines, with the sources.

Countries

Therapeutic areas

Top substances

Names in the registers

Sources and licences

At a glance

Group structure

🇺🇸United States2

Headquarters not stated2

Medicines

Know your medicines, with the sources.

Countries

Therapeutic areas

Top substances

Names in the registers

Sources and licences

At a glance

United States2